ArticleAnnals of oncology : official journal of the European Society for Medical Oncology2016

reply to the letter to the editor 'Possible determinants of VSL#3 probiotic failure in preventing gastrointestinal adverse events associated with dacomitinib in patients with advanced non-small-cell lung cancer enrolled in ARCHER-1042 trial' by Ceccarelli et al.

M E Lacouture et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.